It is also possible that the low-KCTD17 subgroup might represent cases in which compensatory mechanisms are activated in response to liver cell damage and cellular stress during the progression of MASH and cirrhosis, thereby downregulating KCTD17 in specific hepatic cell populations. The gene discussed is KCTD17; the disease is metabolic dysfunction-associated steatohepatitis.